diltiazem has been researched along with nisoldipine in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (29.09) | 18.7374 |
1990's | 21 (38.18) | 18.2507 |
2000's | 11 (20.00) | 29.6817 |
2010's | 7 (12.73) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Horinouchi, M; Komada, F; Nishiguchi, K; Ohmoto, N; Ohnishi, N; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y; Yokoyama, T | 1 |
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dessy, C; Dion, R; Godfraind, T; Salomone, S; Schoevaerts, JC; Verhelst, B | 1 |
Piessens, J; Vrolix, M | 1 |
Addicks, K; Fricke, U; Gielen, W; Klaus, W; Sarram, M; Werner, G | 1 |
Belousov, Y; Kushnaryov, V | 1 |
Abbate, R; Boddi, M; Coppo, M; Gensini, GF; Neri Serneri, GG; Prisco, D; Rostagno, C | 1 |
Beyerle, A; Lehmann, G; Reiniger, G; Rudolph, W; Wolf, H | 1 |
Kilz, U; Knaup, G | 1 |
Jones, AW; Smith, JM | 1 |
Bodewei, R; Hering, S; Schubert, B; Wollenberger, A | 1 |
Bae, SJ; Herbette, LG; Kitamura, S; Sturtevant, JM | 1 |
Frais, MA; Jackson, N; Midtbo, KA; Reynolds, G; Sharma, S; Silke, B; Taylor, SH; Verma, SP | 1 |
Bolger, GT; Ruzycky, A; Triggle, DJ; Yousif, FB | 1 |
Ilias, W; Steinbereithner, K | 1 |
Fujita, I; Irita, K; Minakami, S; Takeshige, K; Yoshitake, J | 1 |
Barbieri, L; Camerini, F; Mestroni, L | 1 |
Karasawa, A; Kubo, K; Nakamizo, N; Oka, T | 1 |
Harrison, GG; Morrell, DF; Wright, IG | 1 |
Hugenholtz, PG; Planellas, J; Serruys, PW; Soward, AL; Suryapranata, H; Vanhaleweyk, G | 1 |
Schwartz, A; Tsai, LI; Wang, T | 1 |
Saida, K; van Breemen, C | 1 |
Francis, PD; Gaum, WE; Hannon, DW; Lathrop, DA; Millard, RW; Nakaya, H; Schwartz, A; Valle-Aguilera, JR | 1 |
Brooks, HL; Gross, GJ; Meils, CM; Warltier, DC | 1 |
Gaum, WE; Kaplan, S; Lathrop, DA; Schwartz, A; Valle, R | 1 |
Birnbaumer, L; Kim, H; Lang, W; Pan, S; Perez-Reyes, E; Schneider, T; Wei, X | 1 |
Cicatiello, AM; de Caprio, L; De Rosa, ML; di Palma, A; Lombardi, L; Pandolfi, E; Rengo, F; Santamaria, F; Sestito, M; Voza, A | 1 |
Onodera, S; Sugawara, H; Tobise, K | 1 |
Fehske, W; Lüderitz, B; Manz, M; Niedeggen, A; Omran, H; Pizzulli, L | 1 |
Akhadov, ShV; Belousov, IuB; Volkov, MG | 1 |
Saida, K; Umeda, M | 1 |
Hair, WM; Hughes, AD; Martin, G; Sever, PS; Sunman, W | 1 |
Agrotis, A; Bobik, A; Little, PJ; Saltis, J | 1 |
Chiba, K; Fukuzawa, A; Ishigai, Y; Mori, T; Shibano, T | 1 |
Kugiyama, K; Ogawa, H; Okumura, K; Tsuchiya, T; Yasue, H | 1 |
Kikuchi, K; Sugawara, H; Tobise, K | 1 |
Curry, P; Dens, J; Hagel, H; Melcher, A | 1 |
Amy, RM; Dolphin, PJ; Graham, SE; Russell, JC | 1 |
Cartin, L; Lounsbury, KM; Nelson, MT | 1 |
Imai, T; Koike, K; Okamoto, T; Shigenobu, K; Tanaka, H; Tanaka, Y; Yamamoto, Y | 1 |
Akimoto, Y; Fujii, A; Matsumoto, H; Noji, I | 1 |
Horinouchi, T; Imai, T; Koike, K; Okamoto, T; Shigenobu, K; Tanaka, H; Tanaka, Y; Yamamoto, Y | 1 |
Fuseler, JW; Hilliard, N; Hockerman, GH; Walsh, KB; Zhang, J | 1 |
Cserne Szappanos, H; Filipovska, A; Hool, L; Johnstone, V; Richman, T; Semsarian, C; Tsoutsman, T; Viola, H | 1 |
3 review(s) available for diltiazem and nisoldipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Calcium antagonists in congestive heart failure].
Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Diltiazem; Felodipine; Heart Failure; Hemodynamics; Humans; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Verapamil | 1988 |
Nisoldipine CC: clinical experience in ischaemic heart disease.
Topics: Amlodipine; Calcium Channel Blockers; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Myocardial Ischemia; Nisoldipine; Randomized Controlled Trials as Topic | 1997 |
9 trial(s) available for diltiazem and nisoldipine
Article | Year |
---|---|
Specific coronary hemodynamic effects of nisoldipine and other vasoactive drugs.
Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Coronary Vessels; Diltiazem; Double-Blind Method; Echocardiography, Doppler; Female; Humans; Male; Molsidomine; Nisoldipine; Vasodilator Agents | 1992 |
The effects of nisoldipine, diltiazem, nifedipine, and verapamil on hemodynamic parameters and red blood cells-platelet interactions in patients with arterial hypertension.
Topics: Adult; Aged; Arteries; Blood Platelets; Blood Pressure; Calcium Channel Blockers; Diltiazem; Erythrocytes; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nisoldipine; Verapamil | 1991 |
[Effectiveness of various combination therapies in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Disease; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Hemodynamics; Humans; Isosorbide Dinitrate; Metoprolol; Nisoldipine; Nitrates | 1990 |
[Nisoldipine in stable angina pectoris. Efficacy and tolerance in comparison with diltiazem].
Topics: Adult; Aged; Angina Pectoris; Diltiazem; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Nisoldipine | 1991 |
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiazem; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Prospective Studies; Random Allocation; Verapamil | 1987 |
Acute coronary hemodynamic effects of equihypotensive doses of nisoldipine and diltiazem.
Topics: Adult; Aged; Benzazepines; Blood Flow Velocity; Calcium Channel Blockers; Coronary Disease; Coronary Vessels; Diltiazem; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Nifedipine; Nisoldipine; Oxygen Consumption; Vascular Resistance | 1985 |
[Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris].
Topics: Administration, Oral; Adult; Angina Pectoris; Diltiazem; Double-Blind Method; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Nisoldipine; Nitroglycerin | 1994 |
[Effect of nisoldipine and diltiazem on systolic and diastolic function of the left ventricle in patients with coronary heart disease].
Topics: Aged; Coronary Disease; Diastole; Diltiazem; Echocardiography, Doppler; Exercise Test; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nisoldipine; Systole; Ventricular Function, Left | 1994 |
[The comparative effect of calcium antagonists on hemodynamics in patients with a stable form of essential hypertension (a randomized study)].
Topics: Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Hemodynamics; Humans; Hypertension; Middle Aged; Nifedipine; Nisoldipine; Time Factors | 1994 |
43 other study(ies) available for diltiazem and nisoldipine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Cell Line; Digoxin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Gene Expression; Humans; Nifedipine; Paclitaxel; RNA, Messenger; Swine; Tritium; Tumor Cells, Cultured; Verapamil; Vinblastine | 2002 |
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
Topics: Calcium; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Nisoldipine; Vasoconstriction; Verapamil | 1992 |
Sialic acid removal modulates the myocardial and vascular activity of calcium channel ligands.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Calcium Channels; Cricetinae; Diltiazem; Dose-Response Relationship, Drug; Electric Stimulation; Fendiline; Gallopamil; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; N-Acetylneuraminic Acid; Neuraminidase; Nisoldipine; Rabbits; Sialic Acids | 1991 |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
Topics: Adult; Blood Platelets; Calcium; Calcium Channel Blockers; Diltiazem; Female; Humans; In Vitro Techniques; Male; Nifedipine; Nisoldipine; Nitrendipine; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Verapamil | 1991 |
Calcium antagonists inhibit elevated potassium efflux from aorta of aldosterone-salt hypertensive rats.
Topics: Aldosterone; Animals; Aorta; Calcium; Calcium Channel Blockers; Diltiazem; Hypertension; In Vitro Techniques; Male; Nisoldipine; Potassium; Potassium Chloride; Rats; Rats, Inbred Strains; Sodium Chloride; Vasoconstriction | 1990 |
Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine.
Topics: Animals; Calcium; Calcium Channel Blockers; Diltiazem; Gallopamil; Glioma; Ion Channels; Neuroblastoma; Neurons; Nifedipine; Nisoldipine; Tumor Cells, Cultured; Verapamil | 1987 |
The effects of calcium channel blocking drugs on the thermotropic behavior of dimyristoylphosphatidylcholine.
Topics: Calcium Channel Blockers; Calorimetry, Differential Scanning; Diltiazem; Dimyristoylphosphatidylcholine; Models, Biological; Nifedipine; Nimodipine; Nisoldipine; Thermodynamics; Verapamil | 1989 |
Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Diltiazem; Gallopamil; Guinea Pigs; In Vitro Techniques; Male; Microsomes; Muscarine; Muscle Contraction; Muscle, Smooth; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Nitrendipine; Potassium; Rats; Rats, Inbred Strains; Receptors, Nicotinic; Urinary Bladder | 1985 |
Potentiation of pancuronium induced neuromuscular blockade by calcium channel blockers in vitro.
Topics: Animals; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Drug Synergism; Gallopamil; Male; Neuromuscular Junction; Nifedipine; Nisoldipine; Pancuronium; Rats; Rats, Inbred Strains; Synaptic Transmission; Verapamil | 1985 |
Calcium channel antagonist induced inhibition of superoxide production in human neutrophils. Mechanisms independent of antagonizing calcium influx.
Topics: Calcium; Calcium Channel Blockers; Diltiazem; Egtazic Acid; Humans; Kinetics; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Nifedipine; Nisoldipine; Protein Kinase C; Superoxides; Tetradecanoylphorbol Acetate; Verapamil | 1986 |
Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Injections, Intravenous; Male; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Rats; Rats, Inbred SHR; Verapamil | 1988 |
The effects of calcium channel blocking drugs on halothane initiation of malignant hyperthermia in MHS swine and on the established syndrome.
Topics: Anesthesia, General; Animals; Calcium Channel Blockers; Diltiazem; Flunarizine; Halothane; Malignant Hyperthermia; Nifedipine; Nisoldipine; Swine; Verapamil | 1988 |
Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum.
Topics: Animals; Calcium Channel Blockers; Calcium-Transporting ATPases; Centrifugation, Density Gradient; Diltiazem; Dogs; Felodipine; In Vitro Techniques; Microsomes; Muscles; Myocardium; Nifedipine; Nisoldipine; Potassium Chloride; Rabbits; Sarcoplasmic Reticulum; Species Specificity; Verapamil | 1984 |
Mechanism of Ca++ antagonist-induced vasodilation. Intracellular actions.
Topics: Animals; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Ion Channels; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nisoldipine; Norepinephrine; Rabbits; Saponins; Vasodilator Agents | 1983 |
Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.
Topics: Animals; Benzazepines; Bundle of His; Calcium Channel Blockers; Culture Techniques; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Atria; Heart Conduction System; Hemodynamics; Humans; Membrane Potentials; Nifedipine; Nisoldipine; Purkinje Fibers; Pyridines; Verapamil | 1982 |
Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.
Topics: Animals; Benzazepines; Calcium; Coronary Circulation; Coronary Disease; Diltiazem; Dogs; Female; Hemodynamics; Male; Nifedipine; Nisoldipine; Pyridines; Verapamil | 1981 |
The effect of diltiazem and nisoldipine on spontaneously active human atrial tissue.
Topics: Atrial Function; Benzazepines; Diltiazem; Electrophysiology; Heart; Humans; Membrane Potentials; Microelectrodes; Nifedipine; Nisoldipine; Pyridines; Tetrodotoxin | 1981 |
Molecular determinants of cardiac Ca2+ channel pharmacology. Subunit requirement for the high affinity and allosteric regulation of dihydropyridine binding.
Topics: Allosteric Regulation; Animals; Calcium Channels; Cell Line; Dihydropyridines; Diltiazem; DNA, Complementary; Female; Kinetics; Ligands; Molecular Structure; Muscle, Skeletal; Myocardium; Nisoldipine; Oocytes; Protein Conformation; Rabbits; Transfection; Xenopus | 1995 |
Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol.
Topics: Animals; Antioxidants; Diltiazem; Fumarates; Heart; In Vitro Techniques; Lipid Peroxidation; Male; Myocardium; Nifedipine; Nisoldipine; Oxidation-Reduction; Oxygen; Propranolol; Rats; Rats, Sprague-Dawley | 1994 |
Improvement of ischemic myocardial dysfunction by nisoldipine in relation to its coronary vasodilating action.
Topics: Animals; Blood Pressure; Coronary Circulation; Diltiazem; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Nifedipine; Nisoldipine; Perfusion; Rabbits; Vasodilator Agents | 1993 |
Effect of calcium antagonists on endothelin-induced contraction of isolated human resistance arteries: differences related to site of origin.
Topics: Adipose Tissue; Adult; Aged; Arteries; Calcium Channel Blockers; Calcium Channels; Diltiazem; Endothelins; Flunarizine; Humans; Membrane Potentials; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Myography; Nimodipine; Nisoldipine; Omentum; Vasoconstriction; Verapamil | 1993 |
Dihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells.
Topics: Calcium Channel Blockers; Cell Division; Cells, Cultured; Dihydropyridines; Diltiazem; DNA; Epidermal Growth Factor; Felodipine; Gene Expression Regulation; Genes, fos; Humans; Immunoblotting; Mammary Arteries; Muscle, Smooth, Vascular; Nisoldipine; Thymidine; Verapamil | 1993 |
Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.
Topics: Acetylcholine; Angina Pectoris; Animals; Arginine Vasopressin; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Disease Models, Animal; Electrocardiography; Male; Nifedipine; Nisoldipine; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Thiazoles; Vasoconstrictor Agents | 1995 |
Heart period variability in patients with variant angina.
Topics: Aged; Angina Pectoris, Variant; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Electrocardiography, Ambulatory; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Nisoldipine; Sympathetic Nervous System | 1996 |
Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
Topics: Adenosine Diphosphate; Animals; Antioxidants; Calcium Channel Blockers; Cell Membrane; Dihydropyridines; Diltiazem; Felodipine; Fumarates; Heart; Iron; Lipid Peroxidation; Male; Myocardium; Nicardipine; Nifedipine; Nisoldipine; Nitrendipine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Verapamil | 1996 |
Cardioprotective and hypolipidemic effects of nisoldipine in the JCR:LA-cp rat.
Topics: Animals; Blood Glucose; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Female; Hypolipidemic Agents; Lipids; Male; Microscopy, Electron, Scanning; Myocardial Contraction; Myocardium; Nifedipine; Nisoldipine; Rats; Rats, Inbred Strains; Sex Characteristics; Time Factors | 1997 |
Coupling of Ca(2+) to CREB activation and gene expression in intact cerebral arteries from mouse : roles of ryanodine receptors and voltage-dependent Ca(2+) channels.
Topics: Animals; Benzylamines; Calcium; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Colforsin; Cyclic AMP Response Element-Binding Protein; Diltiazem; Enzyme Inhibitors; Gene Expression Regulation; Genes, fos; Imidazoles; In Vitro Techniques; Membrane Potentials; Mice; Middle Cerebral Artery; Nisoldipine; Nitroprusside; Posterior Cerebral Artery; Potassium; Proto-Oncogene Proteins c-fos; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Sulfonamides; Transcription, Genetic | 2000 |
Effects of different types of K+ channel modulators on the spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Apamin; Barium; Benzimidazoles; Calcium Channel Blockers; Cation Transport Proteins; Cromakalim; Diltiazem; Ether-A-Go-Go Potassium Channels; Female; Glyburide; Guinea Pigs; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle Contraction; Muscle, Smooth; Nisoldipine; Parasympatholytics; Peptides; Periodicity; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Channels, Voltage-Gated; Pyridines; Small-Conductance Calcium-Activated Potassium Channels; Urinary Bladder | 2001 |
Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Calcium Channel Blockers; Cell Culture Techniques; Cell Division; Collagen; Diltiazem; DNA; ErbB Receptors; Female; Fibroblasts; Flow Cytometry; Gingiva; Gingival Overgrowth; Humans; Male; Middle Aged; Nicardipine; Nifedipine; Nisoldipine; Phenytoin; Radiopharmaceuticals; Statistics as Topic; Tritium; Verapamil | 2001 |
Evidence that action potential generation is not the exclusive determinant to trigger spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Diltiazem; Female; Guinea Pigs; Male; Mibefradil; Muscle Contraction; Muscle, Smooth; Nisoldipine; Urinary Bladder | 2002 |
Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts.
Topics: Adenoviridae; Animals; Calcium; Calcium Channels, L-Type; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Diltiazem; Dose-Response Relationship, Drug; Fibroblasts; Heart Ventricles; Myocardial Contraction; Myocytes, Cardiac; Nisoldipine; Rats | 2007 |
The L-type Ca(2+) channel facilitates abnormal metabolic activity in the cTnI-G203S mouse model of hypertrophic cardiomyopathy.
Topics: Actins; Animals; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cardiomyopathy, Hypertrophic; Cytoskeleton; Diltiazem; Disease Models, Animal; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria, Heart; Mutation; Myocytes, Cardiac; Nisoldipine; Superoxides; Troponin I | 2016 |